Home » Topics » Regulatory

Regulatory
RSS

Lundbeck files for new Alzheimer's indication for Ebixa in Europe

Oct. 25, 2004

Remicade receives European approval for psoriatic arthritis

Oct. 19, 2004

Approval for new Cancidas indication

Oct. 15, 2004

European approval for Protelos

Oct. 6, 2004

Abilify approved for acute bipolar mania

Oct. 5, 2004

FDA approves Remicade as first-line therapy in moderate to severe RA

Oct. 5, 2004

Enbrel approved in E.U. for psoriasis

Oct. 5, 2004

Third indication studied for SGN-30 in new phase II trial

Sep. 29, 2004

Expanded indication for Eloxatin for early stage colon cancer treatment

Sep. 21, 2004

Nexium completes European mutual recognition procedure for new indications

Sep. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...